Respiratory
A New Mechanism of Asthma Described
A New Mechanism of Asthma Described

Limiting Damage from an Asthma Attack Could Halt the Disease

October 2024

WHO Projects Surge in Cancer Cases by 2050
WHO Projects Surge in Cancer Cases by 2050

In 2022, there were 20 million new cancer cases globally, with lung, breast, and colorectal cancers being the most prevalent. Urgent action is warranted.

March 2024

WHO Urges Mask Usage and Reinforcements Against Re
WHO Urges Mask Usage and Reinforcements Against Respiratory Diseases

WHO Director-General, Tedros Adhanom Ghebreyesus, emphasizes the importance of preventive measures, including mask usage, to combat spikes in respiratory illnesses.

Februery 2024

Higher Risk of Emphysema in Marijuana and Cigarett
Higher Risk of Emphysema in Marijuana and Cigarette Smokers

Increased likelihood of lung alveoli damage among marijuana and cigarette smokers, exacerbating emphysema risk.

January 2024

Exploring the Benefits of Prebiotics, Probiotics,
Exploring the Benefits of Prebiotics, Probiotics, and Postbiotics

Beyond digestive health, their positive impacts extend to the skin, respiratory system, and vaginal health.

January 2024

Seasonal Variation in Respiratory Hospital Mortality

Higher risk of hospital mortality from respiratory causes observed during summer compared to winter months.

December 2023

WHO Concerned About Respiratory Diseases in Chines
WHO Concerned About Respiratory Diseases in Chinese Children

Urgent call for additional information on pneumonia cases in children and reinforcement of preventive measures among the population.

December 2023

WHO Identifies JN.1 as New COVID-19 Variant of Int
WHO Identifies JN.1 as New COVID-19 Variant of Interest

Concerns regarding the potential impact of the winter season on respiratory infections prompt the WHO to designate JN.1 as a new variant of interest.

December 2023

Inhaled Amikacin for Preventing Ventilator-Associated Pneumonia

Demonstrated reduction in ventilator-associated pneumonia burden during 28 days of follow-up.

December 2023

Advancements in Severe Asthma Treatment

A Phase 4, Randomized, Multicenter, Open-Label Study explores novel treatment options for severe asthma, offering hope for improved outcomes in affected individuals.

December 2023